Welcome to our dedicated page for Spectral AI SEC filings (Ticker: MDAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Spectral AI, Inc. (MDAI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Spectral AI is a Dallas-based predictive AI company focused on medical diagnostics for wound care, and its filings offer detailed information on the development of its DeepView® System, financial condition, and capital structure.
Through this page, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q, where Spectral AI discusses research and development revenue, gross margins, operating expenses, and the role of its BARDA Project BioShield contract in funding the DeepView technology. These reports also describe risks, regulatory pathways, and the company’s status as an emerging growth company.
Current reports on Form 8-K document material events, such as securities purchase agreements, private placements of warrants and pre-funded warrants, and placement agency arrangements. For example, an 8-K filing describes a securities purchase agreement for common stock, warrants, and pre-funded warrants, including exercise prices, terms, and related registration rights. Such filings outline how Spectral AI raises growth capital to support continued development of the DeepView System and general corporate purposes.
Investors interested in equity and warrant terms can use this page to follow details on listed redeemable warrants trading under the symbol MDAIW, as well as privately placed warrants and pre-funded warrants described in registration statements and 8-K exhibits. Insider transactions reported on Form 4, when available, can help users monitor changes in beneficial ownership by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain key points from lengthy documents, highlight important changes in capital structure or obligations, and surface items related to DeepView’s regulatory progress and BARDA funding. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 filings for MDAI are quickly reflected, giving investors and researchers a structured way to analyze Spectral AI’s regulatory and financial disclosures.
Spectral AI, Inc. ownership disclosure: Hudson Bay Capital Management and Sander Gerber report beneficial ownership of 1,671,416 shares, representing 4.99% of common stock on a defined basis. The reported figure assumes exercise of warrants held by Hudson Bay Master Fund Ltd., subject to a 4.99% Blocker.
The filing cites 31,823,895 shares outstanding as of March 23, 2006 for the percentage calculation and states that Mr. Gerber disclaims beneficial ownership while the Investment Manager may be deemed beneficial owner of the exercisable shares.
Spectral AI, Inc. director John Michael DiMaio reported a compensation-related equity award rather than an open-market trade. He received 100,000 shares of Common Stock as a grant at a stated price of $0.00 per share, increasing his direct holdings to 2,611,227 Common shares after the transaction.
The filing also lists existing equity awards that can convert into Common Stock, including 100,000 underlying shares from restricted stock units at $1.84, 250,000 underlying shares from non-qualified stock options at $1.25, and additional incentive stock options covering 20,352 and 5,292 underlying shares at $1.67 per share, with expirations between 2034 and 2036. Footnotes state that certain stock options are fully vested.
Spectral AI, Inc. director Richard John Cotton reported a compensation-related equity grant. He received 29,850 shares of Common Stock as a grant or award at $0.00 per share, bringing his direct Common Stock holdings to 96,777 shares, including 29,850 restricted stock units (RSUs) that the filing notes as fully vested and issued on April 24, 2026. He also holds fully vested stock options over additional Common Stock, with exercise prices of $1.25 and $1.67 per share and expirations between 2034 and 2035, plus RSU-based rights expiring in 2036. The filing shows no open‑market buying or selling, only an acquisition through a grant and updated holdings.
Spectral AI, Inc. director Marion Ann Snyder reported an equity award and updated her holdings in company stock and derivatives. On April 24, 2026, she received a grant of 25,000 shares of Common Stock, recorded at a price of $0.0000 per share, bringing her direct common stock ownership to 25,000 shares.
She also holds vested non-qualified stock options over 17,717, 50,000, and 13,568 shares of Common Stock with exercise prices of $1.27, $1.25, and $1.67 per share, expiring between 2034 and 2035, plus 25,000 restricted stock units tied to Common Stock, with 50% vesting on April 20, 2026 and the remaining 50% scheduled for April 1, 2027.
Spectral AI, Inc. reported that Chief Executive Officer Vincent S. Capone received a grant of 100,000 shares of Common Stock on April 24, 2026 as a compensation award at an effective price of $0.00 per share. Following this grant, he directly owns 286,450 Common shares. The filing also lists fully vested or vesting equity awards, including restricted stock units tied to 100,000 underlying shares at an exercise price of $1.84, and several incentive and non-qualified stock option grants with exercise prices between $1.20 and $5.54 expiring between 2032 and 2036.
Spectral AI, Inc. detailed an employment agreement with Chief Executive Officer Vincent S. Capone, effective with his previously announced appointment. He will receive a $500,000 annual base salary and is eligible for an annual bonus of up to 100% of salary, but no less than $250,000, based on Board‑set milestones.
Capone will be granted 200,000 RSUs under the 2023 Long Term Incentive Plan, with 50% vesting on April 1, 2026 and 50% on April 1, 2027, and all RSUs vesting immediately before a change of control. If terminated without cause or he resigns for good reason, he is entitled to 12 months of salary, continued benefits participation, and accelerated vesting of equity, subject to a release of claims.
Spectral AI, Inc. is asking stockholders to approve the reservation and potential issuance of up to 8,000,000 shares of common stock to Hudson Bay Master Fund under an existing October 2025 securities purchase agreement. The proxy also covers electing five directors and ratifying Forvis Mazars, LLP as auditor for 2026. The Hudson Bay deal already included the sale of 3,065,000 shares at $1.90, 4,000,000 warrants at a $2.51 exercise price and 935,000 pre-funded warrants, and could further dilute current holders if fully exercised.
Spectral AI, Inc. appointed David McGuire, CPA, as Chief Financial Officer effective May 4, 2026. He brings over 20 years of finance and accounting experience, including senior roles at Solo Brands and EZCORP and a 14-year career at Ernst & Young.
McGuire will receive a $330,000 annual salary, an annual target bonus of up to 30% of salary, and a minimum guaranteed $50,000 bonus for 2026 if he remains employed through six months. His package includes a $10,000 sign-on bonus, eligibility for a 401(k) with a company match, paid time off, and participation in standard benefits.
Subject to board approval, he will be granted stock options to acquire 150,000 common shares at the start-date market price, vesting annually over three years with full vesting upon a change of control. If terminated without cause or he resigns for defined good reason, he is eligible for three months of salary, continued benefits support, and accelerated vesting of equity, conditioned on a release of claims.
Spectral AI, Inc. director John Michael DiMaio reported a stock award of 7,619 shares of Common Stock at $1.58 per share. After this grant, he directly owns 2,511,227 common shares. The award is classified as a grant or other acquisition rather than an open-market purchase.
He also holds incentive stock options and non-qualified stock options over additional Common Stock. Two ISO grants cover 5,292 and 20,352 underlying shares at an exercise price of $1.67, expiring in 2034, and one NQSO grant covers 250,000 underlying shares at $1.25, expiring in 2035. Footnotes state that some options are already fully vested and others vest monthly or upon achieving specified milestones.
Spectral AI, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held on May 29, 2026
The agenda includes election of five directors, ratification of Forvis Mazars, LLP as independent auditors, and approval under Nasdaq Rule 5635(d) to reserve and issue up to 8,000,000 shares of Common Stock in connection with a Securities Purchase Agreement with Hudson Bay Master Fund Ltd. The Purchase Agreement (signed October 22, 2025) originally sold 3,065,000 shares at $1.90 per share and accompanying warrants and pre-funded warrants that could result in issuance of up to 8,000,000 shares; an Exchange Cap limits issuance without further stockholder consent to 5,522,016 shares. Shares outstanding were 31,823,985 as of April 1, 2026. The meeting materials also disclose board composition, director independence determinations, executive officer appointments (CEO appointment of Vincent Capone effective February 9, 2026), executive and director compensation details, and equity plan reserves under the 2023 Long Term Incentive Plan.